SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aurobindo Pharma informs about press release

04 Aug 2026 Evaluate
Aurobindo Pharma has informed that it enclosed copies of the Notice published in the newspapers, Business Standard and Nava Telangana on August 4, 2026, intimating the shareholders about dispatch (through e-mail only) of the Notice of 39th Annual General Meeting of the Company to be held on Thursday, August 27, 2026, at 3:30 pm IST through Video Conferencing (VC) / Other Audio Visual Means(OAVM) and Annual Report for the financial year 2025-26, e-voting information and Book Closure dates.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1655.50 66.00 (4.15%)
07-Aug-2026 14:57 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1941.75
Dr. Reddys Labs. 1167.70
Cipla 1470.40
Lupin 2367.50
Zydus Lifesciences 1115.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: